Patents by Inventor James Anthony Triccas

James Anthony Triccas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prevention and treatment of mycobacterium infection
    Patent number: 9931391
    Abstract: The invention relates to the identification of antigens, including Mycobacterium sulphate assimilation pathway components such as CysD, for preventing and treating Mycobacterium infection, especially but not exclusively Mycobacterium tuberculosis infection; to expression systems including live Mycobacterium for expression of said antigens for prevention and treatment of said infection; and to use of said antigens and expression systems for prevention and treatment of said infection.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: April 3, 2018
    Assignees: The University of Sydney, Centenary Institute of Cancer Medicine and Cell Biology
    Inventors: James Anthony Triccas, Rachel Pinto-Nadanachandran, Warwick John Britton
  • Prevention and Treatment of Mycobacterium Infection
    Publication number: 20170173137
    Abstract: The invention relates to the identification of antigens, including Mycobacterium sulphate assimilation pathway components such as CysD, for preventing and treating Mycobacterium infection, especially but not exclusively Mycobacterium tuberculosis infection; to expression systems including live Mycobacterium for expression of said antigens for prevention and treatment of said infection; and to use of said antigens and expression systems for prevention and treatment of said infection.
    Type: Application
    Filed: February 28, 2017
    Publication date: June 22, 2017
    Inventors: James Anthony Triccas, Rachel Pinto-Nadanachandran, Warwick John Britton
  • Prevention and treatment of mycobacterium infection
    Patent number: 9610337
    Abstract: The invention relates to the identification of antigens, including Mycobacterium sulphate assimilation pathway components such as CysD, for preventing and treating Mycobacterium infection, especially but not exclusively Mycobacterium tuberculosis infection; to expression systems including live Mycobacterium for expression of said antigens for prevention and treatment of said infection; and to use of said antigens and expression systems for prevention and treatment of said infection.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: April 4, 2017
    Assignee: The University of Sydney Centenary Institute of Cancer Medicine and Cell Biology
    Inventors: James Anthony Triccas, Rachel Pinto-Nadanachandran, Warwick John Britton
  • Prevention and Treatment of Mycobacterium Infection
    Publication number: 20160022795
    Abstract: The invention relates to the identification of antigens, including Mycobacterium sulphate assimilation pathway components such as CysD, for preventing and treating Mycobacterium infection, especially but not exclusively Mycobacterium tuberculosis infection; to expression systems including live Mycobacterium for expression of said antigens for prevention and treatment of said infection; and to use of said antigens and expression systems for prevention and treatment of said infection.
    Type: Application
    Filed: December 20, 2012
    Publication date: January 28, 2016
    Inventors: James Anthony Triccas, Rachel Pinto-Nadanachandran, Warwick John Britton